期刊文献+

乳腺癌PCNA、c-erbB-2和CD44V6的表达及临床意义 被引量:1

下载PDF
导出
摘要 目的 探讨乳腺癌PCNA、c-erbB-2、CD44V6的表达与组织学分级、激素受体状态、淋巴结转移等的关系及其临床意义。方法 采用免疫组化S-P法,对42例乳腺癌患者术后病理组织进行检测。结果 PCNA的表达与组织学分级呈正相关(P<0.01),c-erbB-2的表达与雌、孕激素受体状态呈负相关(P<0.01,P<0.05),CD44V6的表达与淋巴结转移呈正相关(P<0.01)。结论 联合检测乳腺癌PCNA、c-erbB-2、CD44V6的表达,有助于预测肿瘤的恶性程度、雌孕激素受体的状况、腋窝淋巴结的状态等,对判断肿瘤对激素治疗和化疗的敏感性,选择合适的辅助治疗及判断其预后有一定帮助。
出处 《徐州医学院学报》 CAS 2004年第6期506-508,共3页 Acta Academiae Medicinae Xuzhou
  • 相关文献

参考文献9

  • 1Elston CW, Ellis IO. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up[J]. Histopathology,1991,19(5):403-410.
  • 2Wright C, Nicholson S, Angus B, et al. Relationship between c-erbB-2 protein product expression and response to endocrine therapy in advanced breast cancer[J]. Br J Cancer,1992,65(1):118-121.
  • 3Mulder JWR, Kruyt PM, Sewnath M, et al. Colorectal cancer prognosis and expression of exon-v6-containing CD44 protein[J]. Lancet,1994,344(26):1470-1474.
  • 4Chu JS, Huang CS, Chang KJ. Proliferating cell nuclear antigen (PCNA) immunolabeling as a prognostic factor in invasive ductal carcinoma of thebreast in Taiwan[J]. Cancer Lett,1998,131(2):145-152.
  • 5Taylor SL, Platt-Higgins A, Rudland PS,et al. Cytoplasmic staining of c-erbB-2 mRNA is not associated with the presence of detectable c-erbB-2 mRNA in breast cancer specimens[J]. Int J Cancer,1998,76(4):459-463.
  • 6Jacobs TW, Gown AM, Yaziji H, et al. HER-2/neu protein expression in breast cancer evaluated by immunohistochemistry. A study of interlaboratory agreement[J]. Am J Clin Pathol,2000,113(2):251-258.
  • 7Jansen RHL, Joosten-Achjanie SR, Arends JW, et al. CD44v6 is nota prognostic factor in primary breast cancer[J]. Ann Oncol,1998,9(1):109-11.
  • 8Kelman Z.PCNA: structure, functions and interactions[J]. Oncogene,1997,14(6): 629-640.
  • 9Aaltomaa S, Lipponen P, Syrjanen K. Prognostic value of cell proliferation in breast cancer as determined by proliferating cell nuclear antigen(PCNA) immunostaining[J]. Anticancer Res,1992,12(4):1281-1286.

同被引文献9

  • 1陈晶,单保恩,陈兴,马洪.兔抗STAT5抗体的制备及其在乳腺癌诊断中的应用[J].细胞与分子免疫学杂志,2004,20(5):615-617. 被引量:1
  • 2陈晶,单保恩,贺占国,董稚明,董金琢,马洪.信号转导和转录激活因子5与β-catenin在乳腺癌组织中的表达及其临床意义[J].中国癌症杂志,2006,16(2):89-92. 被引量:4
  • 3Barash I.Stat5 in the mammary gland:controlling normal development and cancer[J].J Cell Physiol,2006,209(2):305-313.
  • 4Buitenhuis M,Baltus B,Lammers JW,et al.Signal transducer and activator of transcription 5a (STAT5a) is required for eosinophil differentiation of human cord blood-derived CD34+ cells[J].Blood,2003,101(1):134-142.
  • 5Calò V,Migliavacca M,Bazan V,et al.STAT proteins:from normal control of cellular events to tumorigenesis[J].J Cell Physiol,2003,197(2):157-168.
  • 6Darnell JE Jr.STATs and gene regulation[J].Science,1997,277(5332):1630-1635.
  • 7Nevalainen MT,Xie J,Bubendorf L,et al.Basal activation of transcription factor signal transducer and activator of transcription (Stat5) in nonpregnant mouse and human breast epithelium[J].Mol Endocrinol,2002,16(5):1108-1124.
  • 8Yamashita H,Iwase H,Toyama T,et al.Naturally occurring dominant-negative Stat5 suppresses transcriptional activity of estrogen receptors and induces apoptosis in T47D breast cancer cells[J].Oncogene,2003,22(11):1638-1652.
  • 9Bowman T,Garcia R,Turkson J,et al.STATs in oncogenesis[J].Oncogene,2000,19(21):2474-2488.

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部